# FDA 483 - CSL Behring GmbH - April 18, 2024

Source: https://www.globalkeysolutions.net/records/483/csl-behring-gmbh/5e869e2f-39c4-427a-a730-ed3f66a5957b

> FDA 483 for CSL Behring GmbH on April 18, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: CSL Behring GmbH
- Inspection Date: 2024-04-18
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/csl-behring-gmbh/ecc4f35b-aa49-4eda-9463-f8a8d683f896)
- [483 - 2022-03-04](https://www.globalkeysolutions.net/records/483/csl-behring-gmbh/d2f41de4-3753-45ba-9136-fba28e8c9bd9)
- [483 - 2018-05-17](https://www.globalkeysolutions.net/records/483/csl-behring-gmbh/e8c1c8f8-2bbb-4021-a093-576c7317ffce)
- [483 - 2024-04-18](https://www.globalkeysolutions.net/records/483/csl-behring-gmbh/ca2ced1c-5c71-4740-af7b-1686b0a70fc5)
- [WARNING_LETTER - Unknown Date](https://www.globalkeysolutions.net/records/warning_letter/csl-behring-gmbh/da7396b2-3718-41b6-8359-b772ae018755)

## Related Officers

- [Joshua J. Silvestri](https://www.globalkeysolutions.net/people/joshua-j-silvestri/433e29b3-ce5f-44d2-9984-7a6cb61e1824)

Company: https://www.globalkeysolutions.net/companies/csl-behring-gmbh/21a38e53-2e5d-4c9e-a287-79597f091cc6

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd